PRE 发表于 2025-3-25 05:22:23

Submitted on: 11 September 2004.
Revised on: 05 December 2004.
Accepted on: 27 January 2005.

___________________CANCER IMMUNOLOGY IMMUNOTHERAPY

悄悄移动 发表于 2025-3-25 08:53:16

http://reply.papertrans.cn/1/47/4698/4698-22.png

conscribe 发表于 2025-3-25 12:04:21

http://reply.papertrans.cn/1/47/4698/4698-23.png

BINGE 发表于 2025-3-25 17:54:26

Submitted on: 24 December 2014.
Revised on: 17 April 2015.
Accepted on: 13 May 2015.

___________________CANCER IMMUNOLOGY IMMUNOTHERAPY

NUDGE 发表于 2025-3-25 23:21:18

http://reply.papertrans.cn/1/47/4698/4698-25.png

Muscularis 发表于 2025-3-26 00:26:19

Submitted on: 03 November 2009.
Revised on: 31 December 2009.
Accepted on: 12 January 2010.

___________________CANCER IMMUNOLOGY IMMUNOTHERAPY

贝雷帽 发表于 2025-3-26 05:52:57

Submitted on: 23 August 2015.
Revised on: 23 September 2015.
Accepted on: 12 November 2015.

___________________CANCER IMMUNOLOGY IMMUNOTHERAPY

扩张 发表于 2025-3-26 10:54:58

http://reply.papertrans.cn/1/47/4698/4698-28.png

ALTER 发表于 2025-3-26 13:40:26

Submitted on: 23 June 2018.
Revised on: 02 September 2018.
Accepted on: 26 September 2018.

___________________CANCER IMMUNOLOGY IMMUNOTHERAPY

热情的我 发表于 2025-3-26 20:51:47

http://reply.papertrans.cn/1/47/4698/4698-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊CANCER IMMUNOLOGY IMMUNOTHERAPY 2024/2025影响因子:4.605 (CANCER IMMUNOL IMMUN) (0340-7004). (IMMUNOLOGY)(免疫学)Science